Resmed Inc. buy Royal Bank of Canada
Start price
30.01.26
/
50%
€222.50
Target price
30.01.27
-
Performance (%)
-19.06%
Price
08.07.26
€180.10
Summary
This prediction is currently active. The prediction for Resmed Inc. disappoints with a performance of -19.06%. This prediction currently runs until 30.01.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 12.903% | 12.903% |
| iShares Core DAX® | 1.770% | 3.450% |
| iShares Nasdaq 100 | -3.500% | 1.607% |
| iShares Nikkei 225® | -4.942% | 4.221% |
| iShares S&P 500 | 0.300% | 2.580% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Ratings data for RMD provided by MarketBeat